MarginsXMarginsX
Home › Markets › Health Care › AMS

American Shared Hospital Services (AMS)

AMS trades on NYSE in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.07
-0.93% on the day
Market cap
$7.1M
Nano cap
Revenue · 2025
$28.1M
-0.9% on 2024
Net income · 2025
-$1.6M
-5.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/744825/000143774926010731/0001437749-26-010731-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerAMS on NYSE
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year1988
SEC CIK0000744825
SEC industry codeServices-Medical Laboratories
Incorporated inCA

Financials · 2025

LineValue
Revenue$28.1M
Net income-$1.6M
Operating income-$3.6M
Net margin-5.5%
Operating margin-12.8%
Revenue growth-0.9%
Cash$3.5M
Total assets$55.5M
P/E (computed)Net income was not positive
P/S (computed)0.3×

Warning signs

Cash runway
Cash-flow positive
$6.5M cash at June 30, 2026
Share count, 1 year
+2.0%
2025-11-11 to 2026-11-11 · +6.0% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$1.3M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, these conditions raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-13
Cash and burn$6.5M cash; operating cash flow $1.3M a quarter.Report 2026-06-30
Shares outstanding6,675,000 (2026-11-11); 6,543,000 a year earlier; 6,300,000 three years earlier.Cover page 2026-11-11
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBaker Tilly US, LLP, San Francisco, California, United States; changed auditors 1 time in 24 months8-K 4.01 2025-06-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.3M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$8.4M-$514K$2.2M$6.5M$16.2M$30.4M10-Q 2026-08-13
Q1 2026
2026-03-31
$7.1M-$612K$2.1M$5.0M$16.8M$29.1M10-Q 2026-05-14
Q4 2025
2025-12-31
$7.7M-$631K-$704K$3.5M$17.4M$28.1M10-K 2026-03-31
Q3 2025
2025-09-30
$7.2M-$17K$1.7M$5.1M$18.2M$29.4M10-Q/A 2026-01-16
Q2 2025
2025-06-30
$7.1M-$280K-$372K$11.1M$19.1M$29.3M10-Q 2026-08-13
Q1 2025
2025-03-31
$6.1M-$625K$2.5M$11.2M$19.9M$29.2M10-Q 2026-05-14
Q4 2024
2024-12-31
$9.1M-$1.3M$274K$11.0M$20.4M$28.3M10-K 2026-03-31
Q3 2024
2024-09-30
$7.0M-$207K$472K$13.8M$14.4M$25.0M10-Q/A 2026-01-16

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B3
424B32015-09-21
Latest annual report
FORM 10-K
10-K2026-03-31
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-13
Latest current report
FORM 8-K
8-K2026-11-12
Latest proxy
FORM DEFA14A
DEFA14A2026-05-07

Source: SEC EDGAR submissions feed, 775 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.9%
1 month-15.0%
3 months-32.5%
Year to date-48.8%
1 year-51.8%
From 52-week high-52.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
ACHAccendra Health Inc.$0.0857-35.08%$6.6M
ACONAclarion Inc.$1.39-12.58%$4.0M
ADVBAdvanced Biomed Inc.$2.22-12.25%$3.7M
MDXHMDxHealth SA$0.1490+3.40%$14.2M
BGLCBioNexus Gene Lab Corp$0.8200-0.12%$2.4M
SERASera Prognostics Inc.$1.94-3.48%$77.2M
XGNExagen Inc.$3.77-8.72%$96.2M
BDSXBiodesix Inc.$9.00-8.91%$99.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier